Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Trends and Outcomes of Neoadjuvant Chemotherapy for Clinical Stage T1 Pancreatic Cancer
Shruti Koti
, Oliver Standring
, Nandan Vithlani
, Neda Amini
, Danielle Deperalta
, Gary Deutsch
, Martin Karpeh
, Matthew Weiss
,
Neha Lad
Icahn School of Medicine at Mount Sinai
Surgery
Surgical Oncology
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Trends and Outcomes of Neoadjuvant Chemotherapy for Clinical Stage T1 Pancreatic Cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Pancreatic Cancer
100%
Neoadjuvant Chemotherapy
100%
Pancreatic Ductal Adenocarcinoma
50%
Upfront Surgery
37%
Clinical T1
37%
Young Age
25%
Chemotherapy
25%
Improved Survival
25%
Surgery Groups
25%
National Cancer Database
12%
Adjuvant Chemotherapy
12%
Pancreas
12%
Year of Diagnosis
12%
Lymph Node Positive
12%
Neck Tumor
12%
Small Tumor
12%
Neoadjuvant Therapy
12%
Well-differentiated
12%
Surgical Margin
12%
Lymphovascular Invasion
12%
Surgery-first Approach
12%
Early Pancreatic Cancer
12%
Academic Programs
12%
Medicine and Dentistry
Pancreas Cancer
100%
Neoadjuvant Chemotherapy
100%
Clinical Stage
100%
Pancreas Adenocarcinoma
50%
Malignant Neoplasm
12%
Neoplasm
12%
Adjuvant Chemotherapy
12%
Surgical Margin
12%
Lymph Node
12%
Neoadjuvant Therapy
12%
Head Tumor
12%